Skip to Main Content
Table 1. 

Demographic Data and Clinical Findings of PD Patients


PD Patients (n = 13)
Age (years) 62.13 ± 8.874 (39–71) 
Male/female 10/3 
Disease duration (years) 16.31 ± 6.019 (10–29) 
Right-/left-sided disease onset 8/5 
Stimulation duration (months) 32.54 ± 27.573 (6–100) 
Hoehn & Yahr ON-ON 2.23 ± 0.484 (1.5–3) 
Hoehn & Yahr OFF-OFF 3.42 ± 0.703 (2.5–5) 
Levodopa equivalence dosage 363.69 ± 218.955 (54–750) 
Mini Mental Status Examination 28.62 ± 2.29 (24–30) 
Visual acuity test right (%) 73.85 ± 15.021 (50–100) 
Visual acuity test left (%) 72.31 ± 16.909 (50–100) 
Amplitude right (V) 3.02 ± 0.804 (1.1–4.1) 
Amplitude left (V) 3.05 ± 0.736 (2.0–4.5) 
Pulse duration (μsec) 62.31 ± 8.32 (60–90) 
Frequency (Hz) 167.31 ± 27.13 (130–210) 

PD Patients (n = 13)
Age (years) 62.13 ± 8.874 (39–71) 
Male/female 10/3 
Disease duration (years) 16.31 ± 6.019 (10–29) 
Right-/left-sided disease onset 8/5 
Stimulation duration (months) 32.54 ± 27.573 (6–100) 
Hoehn & Yahr ON-ON 2.23 ± 0.484 (1.5–3) 
Hoehn & Yahr OFF-OFF 3.42 ± 0.703 (2.5–5) 
Levodopa equivalence dosage 363.69 ± 218.955 (54–750) 
Mini Mental Status Examination 28.62 ± 2.29 (24–30) 
Visual acuity test right (%) 73.85 ± 15.021 (50–100) 
Visual acuity test left (%) 72.31 ± 16.909 (50–100) 
Amplitude right (V) 3.02 ± 0.804 (1.1–4.1) 
Amplitude left (V) 3.05 ± 0.736 (2.0–4.5) 
Pulse duration (μsec) 62.31 ± 8.32 (60–90) 
Frequency (Hz) 167.31 ± 27.13 (130–210) 

Data are given as absolute values or mean (range) and ±SD.

Close Modal

or Create an Account

Close Modal
Close Modal